Cross-Sector entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. The tracked stories average 2 original sources each. Psychedelics appears in 1 tracked Cross-Sector story from March 17, 2026.
1 verified story tracked
Last mentioned: Mar 17, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. The tracked stories average 2 original sources each. Psychedelics appears in 1 tracked Cross-Sector story from March 17, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Psychedelics. Shared-story counts are live from our verified record — not editorial picks.
A breakthrough comparative study has demonstrated that psychedelic-assisted therapy achieves significantly higher smoking cessation rates than traditional nicotine patches. This discovery suggests a major shift in addiction medicine, potentially disrupting the $25 billion global nicotine replacement therapy market.
Source: mainlinemedianews.com · orlandosentinel.com
